Videos

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory and author of The Price of Global Health, explains why pharmaceutical products tend to cost more in the US than the rest of the world. 

Ed Schoonveld Discusses List Prices for Pharmaceuticals in the US Compared to Other Countries

Articles

Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium? 

The Synergies in Combining Artificial Intelligence and Market Access 

Year-on-year growth in demand is strong, according to the IATA.

Air Cargo Sustains Significant Growth for February

The latest news for pharma industry insiders.

Pharma Pulse 4/4/24: Baltimore Bridge Collapse Upends US Supply Chains, Can Employees Realistically Expect Any Good Jobs for 2024? & more

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

An 'Access' Double-Take: Fresh Views on PAPs and Patient Hubs

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics. 

Does Biosimilar Competition Result in Lower Out-of-Pocket Costs for Patients?

The two company’s will provide consumers with a platform where they can compare drug prices.

Mark Cuban’s Cost Plus Drugs Partners with Price.com

Pharma Pulse 4/3/24: Trends Shaping the Future of Drug Development, Pharmacists Can Help Monitor Cardiometabolic Parameters in Schizophrenia & more

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, explores the two major strategies big pharma companies are employing amid current macro challenges and efforts to offset looming patent losses to blockbuster brands.

News